Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virpax Pharmaceuticals Inc (NQ: VRPX )

0.5670 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5670
Bid (Size) 0.5000 (510)
Ask (Size) 0.5130 (49)
Prev. Close 0.5670
Today's Range 0.5670 - 0.5670
52wk Range 0.3625 - 5.480
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Virpax Pharmaceuticals Stock Gaining On Friday?
Virpax Pharmaceuticals shares are up 59.4% after announcing an extended collaboration with NCATS to advance its NES100 pain management candidate. Virpax also announced results from a minipig Dose Range... 
Via Benzinga

Performance

YTD
-82.23%
-82.23%
1 Month
-8.39%
-8.39%
3 Month
-30.00%
-30.00%
6 Month
-20.25%
-20.25%
1 Year
-88.19%
-88.19%

More News

Read More
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
From Virpax Pharmaceuticals, Inc.
Via Business Wire
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
From Virpax Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
From Spartan Capital Securities, LLC
Via GlobeNewswire
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
From Virpax Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
From Virpax Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
From Virpax Pharmaceuticals, Inc.
Via Business Wire
VRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q2 2024
Via InvestorPlace
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
From Virpax Pharmaceuticals
Via Business Wire
Virpax Regains Compliance with Nasdaq Minimum Bid Price
From Virpax Pharmaceuticals
Via Business Wire
Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Tumbles Over 100 Points; American Express Earnings Beat Views
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.